Luxembourg Approves Key Unified Patent Court Instrument But Uncertainties Continue
Executive Summary
Luxembourg will be hosting the UPC’s Court of Appeal and Registry but it is still not clear when or even whether Europe’s new common patent court will be introduced.
You may also be interested in...
One Less Worry For Europe's Unified Patent Court After UK Ratifies Key Agreement
Europe’s UPC still cannot start until and unless a legal challenge in Germany is settled in favor of the court, but the UK’s ratification this week means that discussions about the UK’s post-Brexit participation in the new systemcan now start properly.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug
The CHMP, the European Medicines Agency’s human medicines committee, will this week decide whether a range of new medicines merit being approved.